Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Josef Coresh

Tracked across 2 events · 52 articles · First seen Aug 05, 2026 · Last active Sep 21, 2026

Sentiment
5
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 10
Tech
Impact: Senior investigator and spokesperson, raising his profile in the field of aging and dementia research.
Aug 05, 2026 · 24 articles
4 0
Tech
The U.S. United States — Food and Drug Administration cleared the PrecivityAD2 blood test, developed by C2N Diagnostics, a startup founded by researchers at Washington University in St. Louis, to help evaluate Alzheimer's disease in…
Impact: Senior author of the NYU Langone Health study showing that avoiding high blood pressure, diabetes and smoking in middle age extends dementia-free life.
Aug 21, 2026 · 28 articles
35 Josef Coresh advised aggressive preventionFDA Clears C2N Alzheimer Blood Test
ERGEN INTELLIGENCE
Track Josef Coresh live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.